80057670 - 21st Current Topics in Gastrointestinal and Liver Pathology- EM

Tuesday, February 15, 2022, 7:45 AM - Thursday, February 15, 2024, 5:15 PM

This 21st annual conference is intended as a practical overview for pathologists who encounter gastrointestinal and liver specimens in daily practice. Interpretation of biopsies of the upper GI tract mucosa and the liver will be addressed, as well as recent advances in pancreatic and biliary pathology. Case presentations will be featured to emphasize presented concepts. Participants should come away with a better understanding of interpretation of mucosal biopsies, liver biopsies, pancreatic/biliary disorders and the application of modern techniques to gastrointestinal disorders.

WHO SHOULD ATTEND
This activity is intended for community pathologists, gastrointestinal specialists, hepatologists and gastrointestinal and hepatology fellows and residents

To purchase and access content, click here: https://oakstone.com/current-topics-in-gastrointestinal-and-liver-pathology 

HOW TO OBTAIN CME CREDIT:
Once the enduring material is completed, you must pass the post-test and complete the evaluation to receive CME credit.

To register for the post test, click on the Start/Resume Quiz above the video player and complete the registration.

Upon completing registration a $45 processing fee is required before taking the online post-test.

Once registered, click “Content & Tests” to complete the post-test and evaluation.

1. Recognize the major histological types of gastric cancer and the variants with clinical relevance
2. Recognize the spectrum of benign/reactive lesions that mimic gastric cancer and its precursor lesions
3. Discuss current practice guidelines in management of gastric intestinal metaplasia.
4. Recognize relevant pathologic features that are necessary for decision making in selecting treatment options of early gastric cancer.
5. Identify helpful diagnostic features on selected challenging cases from the GI consultation service
6. Know the current clinical utility of cell-free DNA in the characterization of gastrointestinal malignancies
7. Distinguish between neuroendocrine neoplasms and other non-neoplastic lesions and neoplasms that can mimic neuroendocrine neoplasms
8. Describe the special stains that aid in the histologic diagnosis of hepatocellular carcinoma
9. Discuss how single cell RNA sequencing and other molecular advances deepen our understanding of “normal” human intestinal crypt niche homeostasis and injury responses across anatomic segments
10. Recognize basic histologic pattern of the most common liver diseases
11. Discuss when colon polyps may be linked to polyposis syndromes
12. Describe medication effects that can mimic gastrointestinal diseases
13. Identify the clinically significant distinct variants of pancreatic cancer

ACCREDITATION STATEMENT:
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT:
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE:
It is the policy of the Johns Hopkins University School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

NOTICE ABOUT OFF-LABEL USE PRESENTATIONS
The Johns Hopkins School of Medicine/Current Topics in Gastrointestinal and Liver Pathology may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.

The Johns Hopkins School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.

PERSONALLY PROVIDED INFORMATION (PPI) POLICY
The Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) is committed to protecting the privacy of its members and customers. If you choose to provide us with personal information by sending an email, or by filling out a form with your personal information and submitting it through our Web site, we use that information to respond to your message and to help us provide you with information, products, or services that you request. We do not give, share, sell, or transfer any personal information to a third party unless required by law. The complete University privacy policy may be accessed via the OCME Web site.

Upon request, OCME will email you information for upcoming activities relevant to your interests. You may unsubscribe at any time.

JOHNS HOPKINS STATEMENT OF RESPONSIBILITY
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

COPYRIGHT INFORMATION
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information and safety profile of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

CONFIDENTIALITY DISCLAIMER for CME ACTIVITIES
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Office any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Office, telephone: 410-614-9900, e-mail: [email protected].

SPECIAL PREREQUISITES FOR PARTICIPANTS:
This is an online enduring material. There are no prerequisites to participate in this activity.

METHOD OF PARTICIPATION:
This enduring material is expected to take approximately 14 hours to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME credit.

The learner’s transcript will be provided after successful completion of the activity evaluation and post-test. A minimum passing rate of at least 70%, within three (3) attempts is needed.

INTERNET CME POLICY:
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with the services that you request.

The contact information is:
Johns Hopkins Privacy Officer
Telephone: 410-735-6509,
E-mail: [email protected].

WARNING:
The copyright proprietor has licensed the picture contained on this recording for private home use only and prohibits any other use, copying, reproduction, or performance in public, in whole or in part (Title 17 USC Section 501 506).

CMEinfo is not responsible in any way for the accuracy, medical or legal content of this recording. You should be aware that substantive developments in the medical field covered by this recording may have occurred since the date of original release.

© 2022 Ebix, Inc. DBA Oakstone Publishing.
CMEinfo is a registered trademark of Oakstone Publishing.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.